Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03638687 · ClinicalTrials.gov registry record
Neuroimaging Epigenetics of Prospective Postpartum Depression Biomarkers
A clinical trial of Bipolar Disorder and Postpartum Depression, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 80
- Enrollment target
- 1
- Study location
NCT03638687: Completed study of Bipolar Disorder and Postpartum Depression, sponsored by Johns Hopkins University.
NCT03638687 is a study of Bipolar Disorder and Postpartum Depression that has completed, run by Johns Hopkins University. The registered enrollment target is 80 participants, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03638687, a study of Bipolar Disorder and Postpartum Depression, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
Through a recent cross species translational experiment, researchers have identified a set of epigenetic marks capable of predicting postpartum depression with greater than 85% accuracy. The researchers are looking to identify a group of women from both the general population and those with a history of mood disorders who are at risk for postpartum depression and obtain brain imaging data at a postpartum time period prior to the onset of depressive symptoms and compare it with those obtained during depressive episodes. The researchers will also evaluate the efficacy of postpartum depression biomarker prediction.
Primary Outcome
One blood sample will be drawn in the third trimester and the epigenetic information obtained will be put into a model of prediction for postpartum depression.
Conditions Studied
Study Locations (1)
Maryland
- Johns Hopkins East Baltimore Medical Campus - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2014-05 |
| Est. Completion | 2020-08 |
What the finished NCT03638687 record still lists
NCT03638687 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (76% lower).
The record links to 2 conditions, with Bipolar Disorder appearing as the primary indexed condition, and to 0 interventions.
NCT03638687 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT03638687 about?
NCT03638687 is a clinical study titled "Neuroimaging Epigenetics of Prospective Postpartum Depression Biomarkers". Through a recent cross species translational experiment, researchers have identified a set of epigenetic marks capable of predicting postpartum depression with greater than 85% accuracy. The researchers are looking to identify a group of women from both the general population and those with a histor...
What is the current status of trial NCT03638687?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2014-05. Estimated completion is 2020-08.
What conditions does trial NCT03638687 study?
This clinical trial studies the following conditions: Bipolar Disorder, Postpartum Depression.
Who is sponsoring clinical trial NCT03638687?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03638687 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bipolar Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03638687's enrollment target sits among peer trials
80 76th of 162 higher than 85 of 162 other Bipolar Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bipolar Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Taking Action for College Students
RECRUITING · NA
-
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
RECRUITING · Phase 3
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Assessing the Impact of Cannabidiol for Anxiety and Depression in Bipolar Disorder
RECRUITING · Phase 2
-
Correcting Circadian Rhythms to Breakthrough in Bipolar Disorder
RECRUITING · Phase 2
-
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia